A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

NCT07466160 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: 7MW3711
DRUG: JS207
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.